Atara Biotherapeutics, Inc. (ATRA) vs MediciNova, Inc. (MNOV)
A side-by-side comparison of Atara Biotherapeutics, Inc. and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRA
Atara Biotherapeutics, Inc.
$9.70HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
MNOV
MediciNova, Inc.
$1.68HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — ATRA vs MNOV
growth of $100 · dividends reinvested · last 10yATRA -98.0% (-32.3%/yr)MNOV -76.5% (-13.5%/yr)MNOV compounded faster over this window
Log scale — wide-divergence pair
ATRA MNOV
ATRA vs MNOV: by the numbers
- •ATRA is the larger company ($87M vs $82M market cap).
- •Both run net losses; ATRA's is the smaller (-269.42% vs -1168.20% net margin).
- •ATRA grew revenue faster over the past five years (56.10% vs -25.46% CAGR).
Metrics side by side
Valuation
| Metric | ATRA | MNOV |
|---|---|---|
| P/S ratio | 14.11 | 89.57 |
| P/B ratio | N/A | 2.21 |
Profitability
| Metric | ATRA | MNOV |
|---|---|---|
| Gross margin | 82.44% | 7.58% |
| Operating margin | 29.69% | -3242.47% |
| Net margin | -269.42% | -1168.20% |
| ROE | N/A | -28.85% |
| ROIC | -100.35% | -31.62% |
Growth (annualized)
| Metric | ATRA | MNOV |
|---|---|---|
| Revenue CAGR (5Y) | 56.10% | -25.46% |
| Total return CAGR (5Y) | -53.60% | -13.62% |
Frequently asked
- Which has grown faster, ATRA or MNOV?
- Over the past five years, ATRA grew revenue faster — ATRA at a 56.10% CAGR versus MNOV at -25.46%.
- How have ATRA and MNOV total returns compared?
- Over the past 10 years, ATRA delivered -32.27% and MNOV delivered -13.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Atara Biotherapeutics ROEMediciNova ROEAtara Biotherapeutics operating marginMediciNova operating marginAtara Biotherapeutics revenue growthMediciNova revenue growthAtara Biotherapeutics free cash flowMediciNova free cash flow
Atara Biotherapeutics & MediciNova appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.